CD274 and non-small cell lung carcinoma: Nevertheless, the focus on tumoral expression of PD-L1 may be too restrictive, given its clonal and spatial heterogeneity, such as is described in early stage NSCLC in the TracerX study [15] and, more recently, in advanced stages [16], that can lead to misinterpretation of PD-L1 status [17].